Author

Joseph Suich

Observed names: J Suich, J. Suich, Joe Suich, Suich, Joseph

Institution: Hull University Teaching Hospitals NHS Trust

Observed institutions: University of Hull, Hull University Teaching Hospitals NHS Trust, York Teaching Hospital NHS Foundation Trust, University of York, Hull York Medical School

ORCID: 0000-0001-5543-6555

Observed ORCID: 0000-0001-5543-6555

OpenAlex ID: A5058151068

Procalcitonin testing combined with NEWS2 evaluation compared with usual care based on NEWS2 for identification of sepsis and antibiotic initiation in the emergency department in England and Wales (PRONTO): a multicentre, randomised, controlled, open-label, phase 3 trial

2026 · Stacy Todd, Joanne Euden, et al. · The Lancet Respiratory Medicine · 9

Evaluation of in vitro activity of fosfomycin, and synergy in combination, in Gram-negative bloodstream infection isolates in a UK teaching hospital

2022 · Joseph Suich, Damian Mawer, et al. · Journal of Medical Microbiology · 8

Travel-associated carbapenem-resistant organisms at a time of increasing geopolitical instability: a UK perspective

2025 · S.J.C. Pallett, S.E. Boyd, et al. · Journal of Hospital Infection · 1

P17 Experience of longer-term use of dalbavancin in the OPAT setting

2026 · Joseph Suich, Joanne Delahay, et al. · JAC-Antimicrobial Resistance

P13 Evaluation of in vitro activity of double β-lactam ‘therapy’ in ESBL+/CPE+ Escherichia coli—what is the association between ‘synergy’ and in vitro susceptibility?

2024 · J Suich, M Van Der Woude, et al. · JAC-Antimicrobial Resistance

P11 Evaluation of in vitro activity of double β-lactam ‘therapy’ in Escherichia coli: what is the association between ‘synergy’ and in vitro susceptibility?

2023 · J Suich, M Van Der Woude, et al. · JAC-Antimicrobial Resistance

25 Establishing the Covid Medicine Delivery Unit: Activity and Outcomes across Humber Coast and Vale

2022 · Katie Drury, Kamla Elgizouli, et al. · Clinical Infection in Practice

P11 Evaluation of in vitro activity of double β-lactam therapy and relationship with PBP activity in Escherichia coli isolates

2022 · J Suich, M Van der Woude, et al. · JAC-Antimicrobial Resistance

In vitro activity of fosfomycin, and synergy in combination, against Gram negative bloodstream infection isolates in a UK hospital

2020 · Joseph Suich, Damian Mawer, et al. · Access Microbiology

QT Peak Prolongation Predicts Cardiac Death Following Stroke

2015 · Wong, Kenneth Y K, MacWalter, Ronald S, et al. · Journal of Cardiology & Current Research

Works count: 10

Citation count: 18

H-index: 2

I10-index: